YAMATO Study (Tissue-Type Plasminogen Activator and Edaravone Combination Therapy).
Aoki J, Kimura K, Morita N, Harada M, Metoki N, Tateishi Y, Todo K, Yamagami H, Hayashi K, Terasawa Y, Fujita K, Yamamoto N, Deguchi I, Tanahashi N, Inoue T, Iwanaga T, Kaneko N, Mitsumura H, Iguchi Y, Ueno Y, Kuramoto Y, Ogata T, Fujimoto S, Yokoyama M, Nagahiro S; YAMATO Study Investigators.
Aoki J, et al. Among authors: fujimoto s.
Stroke. 2017 Mar;48(3):712-719. doi: 10.1161/STROKEAHA.116.015042. Epub 2017 Jan 24.
Stroke. 2017.
PMID: 28119434
Clinical Trial.